Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Using inorganic nitrate to treat high blood pressure in pregnant women

Official title: Inorganic Nitrate Supplementation for Blood Pressure Control in Chronic Hypertensive Pregnancies From the 2nd Trimester (NIT_CH): a Triple-Blind Randomized Placebo-Controlled Trial

Run by University of Sao Paulo · NCT06105775 · Data updated 2026-11-12

This study is testing if taking inorganic nitrate can help pregnant women with high blood pressure improve their blood pressure and support their baby's health.

More Hypertension trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment144 (estimated)
SponsorUniversity of Sao Paulo
Academic / other
Locations1 site (Ribeirão Preto, São Paulo)
StatusRecruiting
StartedMarch 6, 2025
Main results expectedDecember 2026
Study endsJuly 2027
Registry record updatedApril 20, 2026
Trial IDNCT06105775 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pregnant women with chronic hypertension who are less than 16 weeks gestation and currently on monotherapy with methyldopa.

Probably not a fit

Patients with uncontrolled chronic hypertension or those with multiple pregnancies may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of inorganic nitrate supplementation on pregnant women diagnosed with chronic hypertension. Eligible participants will be randomly assigned to receive either a capsule containing inorganic nitrate or a placebo starting from the 16th week of their pregnancy. The study aims to assess the impact of this supplementation on blood pressure and uterine artery health, which are crucial for both maternal and fetal well-being. Participants will continue their standard medications for preeclampsia prophylaxis throughout the study.

Why it matters

Potential benefit: If successful, this approach could provide a safer alternative treatment for managing hypertension during pregnancy.

How similar studies have gone: Preliminary studies have shown promising results with inorganic nitrate supplementation, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant women diagnosed with chronic hypertension (systolic blood pressure above 140 mmHg and/or diastolic blood pressure above 90 mmHg before pregnancy or before 20 weeks of gestation) as defined by the Brazilian Network for Studies on Hypertension in Pregnancy (RBEHG, Brazilian acronym) Protocol and Chronic Hypertension/Preeclampsia by the Brazilian Federation of Gynecology and Obstetrics Associations (FEBRASGO, Brazilian acronym) Protocol.
* Patients on monotherapy with methyldopa as treatment at the time of inclusion.
* Women with less than 16 weeks of gestation confirmed by first-trimester ultrasonography confirming gestational age.

Exclusion Criteria:

* Multiple pregnancies, age below 18 years old, inability to provide informed consent, or history of low adherence to medication therapy.
* Patients with uncontrolled chronic hypertension, with blood pressure values above 160x110mmHg.
* History of food allergies, especially hypersensitivity to beetroot.
* Users of illicit drugs, smokers, or alcohol abusers.
* Diagnosis of coronary artery disease, congestive heart failure (moderate to severe), moderate to severe liver failure, chronic renal insufficiency (with plasma creatinine clearance less than 30 ml/min/1.73 m² of body surface), pre-existing type 1 diabetes, and type 2 diabetes.
* Pregnant women who frequently used non-steroidal anti-inflammatory drugs, nasal decongestants, and anorectics before getting pregnant; users of proton pump inhibitors and H2 receptor antagonists or any other medication that interferes with stomach pH, starting 2 weeks before the beginning and continuing throughout the remainder of the study.

Where it's running

  • Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP
    Ribeirão Preto, São Paulo, Brazil
    Recruiting

Study contacts

  • Principal investigator: Ricardo C Cavalli, Dr — Medical School of Ribeirao Preto, USP
  • Study coordinator: Ricardo C Cavalli, Dr
  • Email: rcavalli@fmrp.usp.br
  • Phone: +55166021000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.